Dysregulation of HB-EGF shedding is implicated in several diseases, such as cardiovascular pathologies, cystic fibrosis, and various cancers, including ovarian, hepatocellular, pancreatic, gastric, breast, and colon cancers, melanoma, glioma, and glioblastoma. The gene discussed is HBEGF; the disease is cancer.